🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
70 results for “Amgen”
MedicineActive substanceLicence holderStatus
AMGEVITA 20 mg solution for injection in pre-filled syringe
EU/1/16/1164/001
Adalimumab Amgen Europe B.V.,
AMGEVITA 20 mg solution for injection in pre-filled syringe
EU/1/16/1164/010
Adalimumab Amgen Europe B.V.,
AMGEVITA 40 mg solution for injection in pre-filled pen
EU/1/16/1164/014- 016
Adalimumab Amgen Europe B.V.,
AMGEVITA 40 mg solution for injection in pre-filled syringe
EU/1/16/1164/002-009
Adalimumab Amgen Europe B.V.,
AMGEVITA 40 mg solution for injection in pre-filled syringe
EU/1/16/1164/011-013
Adalimumab Amgen Europe B.V.,
AMGEVITA 80 mg solution for injection in pre-filled pen
EU/1/16/1164/020- 022
Adalimumab Amgen Europe B.V.,
AMGEVITA 80 mg solution for injection in pre-filled syringe
EU/1/16/1164/017-019
Adalimumab Amgen Europe B.V.,
Aranesp 10 micrograms solution for injection in pre-filled pen
EU/1/01/185/045, 057
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 10 micrograms solution for injection pre-filled syringe
EU/1/01/185/001-002
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 100 micrograms solution for injection in pre-filled pen
EU/1/01/185/053, 065
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 100 micrograms solution for injection pre-filled syringe
EU/1/01/185/017-018
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 130 micrograms solution for injection in pre-filled pen
EU/1/01/185/072, 073
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 15 micrograms solution for injection in pre-filled pen.
EU/1/01/185/046, 058
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 15 micrograms solution for injection pre-filled syringe
EU/1/01/185/003-004
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 150 micrograms solution for injection in pre-filled pen
EU/1/01/185/054, 066
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 150 micrograms solution for injection pre-filled syringe
EU/1/01/185/019-020
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 20 micrograms solution for injection in pre-filled pen
EU/1/01/185/047, 059
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 20 micrograms solution for injection pre-filled syringe
EU/1/01/185/005-006
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 30 micrograms solution for injection in pre-filled pen
EU/1/01/185/048, 060
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 30 micrograms solution for injection pre-filled syringe
EU/1/01/185/007-008
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 300 micrograms solution for injection in pre-filled pen
EU/1/01/185/055, 067
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 300 micrograms solution for injection pre-filled syringe
EU/1/01/185/021-022
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 40 micrograms solution for injection in pre-filled pen
EU/1/01/185/049, 061
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 40 micrograms solution for injection pre-filled syringe
EU/1/01/185/009-010
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 50 micrograms solution for injection in pre-filled pen
EU/1/01/185/050, 062
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 50 micrograms solution for injection pre-filled syringe
EU/1/01/185/011-012
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 500 micrograms solution for injection in pre-filled pen
EU/1/01/185/056, 068
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 500 micrograms solution for injection pre-filled syringe
EU/1/01/185/031-032
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 60 micrograms solution for injection in pre-filled pen
EU/1/01/185/051, 063
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 60 micrograms solution for injection pre-filled syringe
EU/1/01/185/013-014
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 80 micrograms solution for injection in pre-filled pen
EU/1/01/185/052, 064
Darbepoetin alfa Amgen Europe B.V.,
Aranesp 80 micrograms solution for injection pre-filled syringe
EU/1/01/185/015-016
Darbepoetin alfa Amgen Europe B.V.,
BEKEMV 300 mg Concentrate for solution for infusion
EU/1/23/1727/001
Eculizumab Amgen Technology (Ireland) Unlimited Company
BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion
EU/1/15/1047/001
Blinatumomab Amgen Europe B.V.,
Imlygic 10e6 plaque forming units (PFU)/mL solution for injection
EU/1/15/1064/001
Talimogene laherparepvec Amgen Europe B.V.
Imlygic 10e8 plaque forming units (PFU)/mL solution for injection
EU/1/15/1064/002
Talimogene laherparepvec Amgen Europe B.V.
KANJINTI 150 mg powder for concentrate for solution for infusion
EU/1/18/1281/001
Trastuzumab Amgen Europe B.V.
KANJINTI 420 mg powder for concentrate for solution for infusion
EU/1/18/1281/002
Trastuzumab Amgen Europe B.V.
Kyprolis 60 mg powder for solution for infusion
EU/1/15/1060/001
Carfilzomib Amgen Europe B.V.,
LUMYKRAS 120 mg film-coated tablets
EU/1/21/1603/001-003
Sotorasib Amgen Europe B.V.,
LUMYKRAS 240 mg film-coated tablets
EU/1/21/1603/004
Sotorasib Amgen Europe B.V.,
MVASI 25 mg/mL Concentrate for solution for infusion
EU/1/17/1246/001-002
Bevacizumab Amgen Technology (Ireland) Unlimited Company
Neulasta 6 mg solution for injection
EU/1/02/227/001-002
Pegfilgrastim Amgen Europe B.V.,
Neupogen 30 MU (0.3 mg/ml) Solution for injection filgrastim
PA1026/001/001
Filgrastim Amgen Europe B.V., Marketed
Neupogen Singleject 30 MU/0.5 ml Solution for injection in a pre-filled syringe filgrastim
PA1026/001/007
Filgrastim Amgen Europe B.V., Marketed
Neupogen Singleject 48 MU/0.5 ml Solution for injection in a pre-filled syringe filgrastim
PA1026/001/008
Filgrastim Amgen Europe B.V., Marketed
Nplate 250 micrograms
EU/1/08/497/1,3
Romiplostim Amgen Europe B.V.,
Nplate 250 micrograms /500 micrograms
EU/1/08/497/5-8
Romiplostim Amgen Europe B.V.,
Nplate 500 micrograms
EU/1/08/497/2,4
Romiplostim Amgen Europe B.V.,
Otezla 10 mg film-coated tablets Otezla 20 mg film-coated tablets
EU/1/14/981/004
Apremilast, Apremilast Amgen Europe B.V.,
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.